LDE225 (sonidegib)

sonidegib · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for LDE225 (sonidegib), covering 2015-09-21 to 2018-12-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of LDE225 (Sonidegib) in Combination With Docetaxel in Triple Negative (TN) Advanced Breast Cancer (ABC) Patients [Phase 1]

See pricing